BORTEZOMIB INJECTION 2MG – Third Party Manufacturing | Medizia Biotech

BORTEZOMIB INJECTION 2MG is a premium-quality anti-cancer injectable manufactured by Medizia Biotech, a trusted name in oncology pharmaceutical manufacturing in India. Bortezomib is a proteasome inhibitor widely prescribed for the treatment of Multiple Myeloma and Mantle Cell Lymphoma. Manufactured in WHO-GMP compliant facilities, our product meets stringent quality standards for hospitals, oncology centers, distributors, and exporters.

Medizia Biotech offers Third Party Manufacturing and Contract Manufacturing services for Bortezomib Injection 2mg with customized packaging, private labeling, and regulatory support. We provide ready stock availability, low MOQ, bulk production, and timely delivery across India and international markets. Our manufacturing capabilities make us the preferred partner for pharmaceutical companies, institutional suppliers, government tenders, and healthcare distributors seeking reliable oncology injection manufacturing.

If you are looking for a Bortezomib Injection Manufacturer in India, Bortezomib Injection Supplier, Bortezomib Injection Exporter, or Third Party Manufacturer of Bortezomib Injection, Medizia Biotech delivers high-quality products with competitive pricing, consistent supply, and complete customer support.